Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

High Ingredient Prices Increase Supply Chain Risks – FDA Compliance Exec

This article was originally published in The Tan Sheet

Executive Summary

Rising ingredient prices should raise red flags for dietary supplement firms that lack supply chain oversight, FDA compliance official Deborah Autor said

You may also be interested in...



Senate Food Safety Bill Continues Congressional Quest To Expand FDA Powers

Senate legislation to reform FDA food safety enforcement has garnered bipartisan and industry support since its introduction July 31, with proposals to boost the agency's authority in the wake of recent concerns about imports and a salmonella outbreak linked to produce

FDA Adds $24.2 Million To Unapproved Drug Initiative Scorecard

Two weeks after FDA officials attempted to explain how well the Center for Drug Evaluation and Research's unapproved drug initiative is working, the agency showed how actions often speak louder than words

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

Topics

UsernamePublicRestriction

Register

PS102146

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel